Newsroom

Biotech investors: Stop expecting CRISPR science to make big leaps

CRISPR technologies have tremendous potential to improve the health of patients with hard-to-cure or incurable illnesses. There are many valuable wins we can achieve for patients suffering from the most intractable cancers, where the science advances in small, non-glamorous increments yet the lifesaving impact for patients could not be more significant. Join leaders in the field Eric Kmiec, Ph.D., and Kelly Banas, Ph.D., as they examine the current layout of the field, the benchmarks of science compared to the challenges of investment, and their hopes for a scientific field that examines CRISPR with rigor and caution.

Browse more Stories

NEWS 10 October 2024

Women of Influence 2024: How 36 businesswomen are shaping Greater Philadelphia

NEWS 11 September 2024

Delaware Tech: A National Leader in Gene-Editing Research

NEWS 5th June 2024

Where does Delaware fit with the regional precision medicine hub?

Upcoming Presentations

Delaware's DNA 2025 Life Science Conference

Date 8 May 2025

Location Chase Center on the Riverfront, Wilmington, DE

Presenter Eric Kmiec

4th In Vivo Cell Engineering & Gene Editing Summit 2025

Date 3-5 June 2025

Location Boston, MA

Presenter Dr. Eric Kmiec

Press Releases

PRESS 18 December 2024

ChristianaCare’s Gene Editing Institute Earns Prestigious Spot on The Scientist’s Top 10 Innovations List for CRISPR in a Box™

ChristianaCare’s Gene Editing Institute’s CRISPR in a Box™ teaching toolkit has been named the #2 innovation on The Scientist’s Top 10 Innovations list for 2024. This cutting-edge toolkit has already empowered over 1,000 students this year, providing a hands-on experience with one of the most exciting technologies in modern science.

PRESS 15 October 2024

Scientists Use CRISPR Tools to Safely Disable Gene Mutation Linked to Advanced Skin Cancer

In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of this dangerous skin cancer that renders promising treatments ineffective.

Carolina Partners with ChristianaCare Gene Editing Institute to Launch CRISPR in a Box™ Kits for High School Science Labs

Carolina and the Gene Editing Institute introduce Nobel Prize-winning technology and STEM 2023 Awards Finalist kit to give students hands-on, cutting-edge lab experience of cell-free gene editing.

Need more information?

For press inquiries, please contact William Schmitt at WSchmitt@Christianacare.org. For inquiries about presentations and events, email geneeditinginstitute@christianacare.org.